In accordance with Article 13 of Law No. 104-12 on freedom of prices and competition and Article 10 of Decree No. 2-14-652 issued for its implementation, as amended and supplemented, the Competition Council makes available to the public the \u201csummary of the operation\u201d below, containing the information provided by the parties.<\/p>\n
This information has been prepared by the notifying parties, who are solely responsible. Inaccurate or distorted information contained therein does not in any way prejudge the Competition Council’s position on the proposed operation.<\/p>\n
The publication of this press release does not attest to the completeness of the file provided for in Article 9 of Decree No. 2-14-652 issued for the implementation of Law No. 104-12 on freedom of prices and competition as amended and supplemented.<\/p>\n
Names of companies and individuals involved:<\/strong><\/p>\n Nature of the operation<\/strong><\/p>\n Economic sector concerned:<\/strong><\/p>\n Deadline for interested third parties to submit their observations:<\/strong><\/p>\n NON-CONFIDENTIAL SUMMARY OF THE OPERATION PROVIDED BY THE PARTIES<\/strong><\/p>\n The Competition Council has received notification of an economic concentration operation concerning the acquisition by the company \u201cSoludia Maghreb SA\u201d of assets related to the manufacturing activity of hemodialysis concentrates of the company \u201cFresenius Medical Care Pharma Africa SA\u201d.<\/p>\n \u201cSoludia Maghreb SA\u201d is a Moroccan joint stock company, registered in the commercial register of Temara under number 144277 and with its registered office at Industrial Zone No. 19 Sidi Yahya Zaers Tamesna, Temara, Kingdom of Morocco. It specializes in the manufacture of concentrates for hemodialysis and more generally, the manufacture, import, export, wholesale distribution, and sale of pharmaceutical products, medical devices, and dietary supplements.<\/p>\n \u201cFresenius Medical Care Pharma Africa SA\u201d is a Moroccan joint stock company, registered in the commercial register of Casablanca under number 833995 and with its registered office at Technopole Zone of Mohammed V Airport, Casablanca, Morocco. Its activities include the manufacture, promotion, distribution, and commercialization of dialysis products.<\/p>\n <\/p>\n Done in Rabat on January 28, 2025<\/p>\n","protected":false},"excerpt":{"rendered":" In accordance with Article 13 of Law No. 104-12 on freedom of prices and competition and Article 10 of Decree No. 2-14-652 issued for its implementation, as amended and supplemented, the Competition Council makes available to the public the \u201csummary of the operation\u201d below, containing the information provided by the parties. This information has been prepared by the notifying parties, who are solely responsible. Inaccurate or distorted information contained therein does not in any way prejudge the Competition Council’s position on the proposed operation. The publication of this press release does not attest to the completeness of the file provided for in Article 9 of Decree No. 2-14-652 issued for the implementation of Law No. 104-12 on freedom of prices and competition as amended and supplemented. Names of companies and individuals involved: The acquirer: \u201cSoludia Maghreb SA\u201d; The target: \u201cFresenius Medical Care Pharma Africa SA\u201d. Nature of the operation Asset acquisition. Economic sector concerned: Pharmaceutical industry focused on the manufacture of hemodialysis concentrates. Deadline for interested third parties to submit their observations: 10 days from the date of publication of this press release, i.e. February 10, 2025. NON-CONFIDENTIAL SUMMARY OF THE OPERATION PROVIDED BY THE PARTIES The Competition Council has received notification of an economic concentration operation concerning the acquisition by the company \u201cSoludia Maghreb SA\u201d of assets related to the manufacturing activity of hemodialysis concentrates of the company \u201cFresenius Medical Care Pharma Africa SA\u201d. \u201cSoludia Maghreb SA\u201d is a Moroccan joint stock company, registered in the commercial register of Temara under number 144277 and with its registered office at Industrial Zone No. 19 Sidi Yahya Zaers Tamesna, Temara, Kingdom of Morocco. It specializes in the manufacture of concentrates for hemodialysis and more generally, the manufacture, import, export, wholesale distribution, and sale of pharmaceutical products, medical devices, and dietary supplements. \u201cFresenius Medical Care Pharma Africa SA\u201d is a Moroccan joint stock company, registered in the commercial register of Casablanca under number 833995 and with its registered office at Technopole Zone of Mohammed V Airport, Casablanca, Morocco. Its activities include the manufacture, promotion, distribution, and commercialization of dialysis products. Done in Rabat on January 28, 2025<\/p>\n","protected":false},"author":5,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[352],"tags":[],"class_list":["post-40116","post","type-post","status-publish","format-standard","hentry","category-press-releases"],"acf":[],"yoast_head":"\n\n
\n
\n
\n